Cargando…
N-glycosylation, a leading role in viral infection and immunity development
N-linked protein glycosylation is an essential co-and posttranslational protein modification that occurs in all three domains of life; the assembly of N-glycans follows a complex sequence of events spanning the (Endoplasmic Reticulum) ER and the Golgi apparatus. It has a significant impact on both p...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8974804/ https://www.ncbi.nlm.nih.gov/pubmed/35364718 http://dx.doi.org/10.1007/s11033-022-07359-4 |
_version_ | 1784680279392124928 |
---|---|
author | Pandey, Vijay Kant Sharma, Rajani Prajapati, Gopal Kumar Mohanta, Tapan Kumar Mishra, Awdhesh Kumar |
author_facet | Pandey, Vijay Kant Sharma, Rajani Prajapati, Gopal Kumar Mohanta, Tapan Kumar Mishra, Awdhesh Kumar |
author_sort | Pandey, Vijay Kant |
collection | PubMed |
description | N-linked protein glycosylation is an essential co-and posttranslational protein modification that occurs in all three domains of life; the assembly of N-glycans follows a complex sequence of events spanning the (Endoplasmic Reticulum) ER and the Golgi apparatus. It has a significant impact on both physicochemical properties and biological functions. It plays a significant role in protein folding and quality control, glycoprotein interaction, signal transduction, viral attachment, and immune response to infection. Glycoengineering of protein employed for improving protein properties and plays a vital role in the production of recombinant glycoproteins and struggles to humanize recombinant therapeutic proteins. It considers an alternative platform for biopharmaceuticals production. Many immune proteins and antibodies are glycosylated. Pathogen’s glycoproteins play vital roles during the infection cycle and their expression of specific oligosaccharides via the N-glycosylation pathway to evade detection by the host immune system. This review focuses on the aspects of N-glycosylation processing, glycoengineering approaches, their role in viral attachment, and immune responses to infection. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s11033-022-07359-4. |
format | Online Article Text |
id | pubmed-8974804 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer Netherlands |
record_format | MEDLINE/PubMed |
spelling | pubmed-89748042022-04-04 N-glycosylation, a leading role in viral infection and immunity development Pandey, Vijay Kant Sharma, Rajani Prajapati, Gopal Kumar Mohanta, Tapan Kumar Mishra, Awdhesh Kumar Mol Biol Rep Review N-linked protein glycosylation is an essential co-and posttranslational protein modification that occurs in all three domains of life; the assembly of N-glycans follows a complex sequence of events spanning the (Endoplasmic Reticulum) ER and the Golgi apparatus. It has a significant impact on both physicochemical properties and biological functions. It plays a significant role in protein folding and quality control, glycoprotein interaction, signal transduction, viral attachment, and immune response to infection. Glycoengineering of protein employed for improving protein properties and plays a vital role in the production of recombinant glycoproteins and struggles to humanize recombinant therapeutic proteins. It considers an alternative platform for biopharmaceuticals production. Many immune proteins and antibodies are glycosylated. Pathogen’s glycoproteins play vital roles during the infection cycle and their expression of specific oligosaccharides via the N-glycosylation pathway to evade detection by the host immune system. This review focuses on the aspects of N-glycosylation processing, glycoengineering approaches, their role in viral attachment, and immune responses to infection. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s11033-022-07359-4. Springer Netherlands 2022-04-01 2022 /pmc/articles/PMC8974804/ /pubmed/35364718 http://dx.doi.org/10.1007/s11033-022-07359-4 Text en © The Author(s), under exclusive licence to Springer Nature B.V. 2022 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Review Pandey, Vijay Kant Sharma, Rajani Prajapati, Gopal Kumar Mohanta, Tapan Kumar Mishra, Awdhesh Kumar N-glycosylation, a leading role in viral infection and immunity development |
title | N-glycosylation, a leading role in viral infection and immunity development |
title_full | N-glycosylation, a leading role in viral infection and immunity development |
title_fullStr | N-glycosylation, a leading role in viral infection and immunity development |
title_full_unstemmed | N-glycosylation, a leading role in viral infection and immunity development |
title_short | N-glycosylation, a leading role in viral infection and immunity development |
title_sort | n-glycosylation, a leading role in viral infection and immunity development |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8974804/ https://www.ncbi.nlm.nih.gov/pubmed/35364718 http://dx.doi.org/10.1007/s11033-022-07359-4 |
work_keys_str_mv | AT pandeyvijaykant nglycosylationaleadingroleinviralinfectionandimmunitydevelopment AT sharmarajani nglycosylationaleadingroleinviralinfectionandimmunitydevelopment AT prajapatigopalkumar nglycosylationaleadingroleinviralinfectionandimmunitydevelopment AT mohantatapankumar nglycosylationaleadingroleinviralinfectionandimmunitydevelopment AT mishraawdheshkumar nglycosylationaleadingroleinviralinfectionandimmunitydevelopment |